medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-13-114-123medsovet-2616Research ArticleИНФЕКЦИИINFECTIONSОстрый цистит в практике акушера-гинекологаAcute cystitis in the practice of an obstetrician-gynecologistКаптильныйВ. А.KaptilnyyV. A.

к.м.н., доцент кафедры акушерства и гинекологии № 1 лечебного факультета

Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)РоссияFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian Federation201825092018013114123Copyright © Каптильный В.А., 20182018Каптильный В.А.Kaptilnyy V.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2616

В обзоре литературы рассматриваются современные данные о диагностике и лечении острого цистита. Освещены вопросы эпидемиологии и этиологии острого цистита. Приводятся основные и альтернативные схемы лечения острого цистита с позиции доказательной медицины.

This review of literature discusses modern data on the diagnosis and treatment of the acute cystitis. Epidemiology and etiology of acute cystitis are described. The basic and alternative treatment protocols for the acute cystitis are presented from the documented medicine viewpoint.

инфекция мочевыводящих путейциститФосфомицинurinary tract infectioncystitisfosfomicinReferencesFoxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am, 2014, 28: 1.Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am, 2014, 28: 1.Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat, 2011, 13: 1.Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat, 2011, 13: 1.Каптильный В.А. Инфекция мочевыводящих путей во время беременности. Архив акушерства и гинекологии им. В.Ф. Снегирева, 2015, 2(4): 10-19.Kaptilny VA. Urinary tract infection during pregnancy. Arkhiv Akusherstva i Ginekologii Im. V.F. Snegireva, 2015, 2 (4): 10-19.Бахарева И.В. Инфекции мочевыводящих путей у беременных: профилактика и лечение. Акушерство и гинекология, 2018, 3: 129- 137.Bakhareva IV. Urinary tract infection in pregnant women: prevention and treatment. Akusherstvo i Ginekologiya, 2018, 3: 129-137.Каптильный В.А. Течение и исходы беременности у пациенток с бессимптомной бактериурией: автореферат дис. ... к.м.н. М., 2008. 25 с.Kaptilny VP. The course and outcome of pregnancy in patients with asymptomatic bacteriuria: extended abstract of PhD (medicine) Dissertation. M., 2008. 25 p.Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis, 2007, 45: 273.Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis, 2007, 45: 273.Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med, 2012, 366: 1028.Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med, 2012, 366: 1028.Gupta K, Trautner B. In the clinic. Urinary tract infection. Ann Intern Med, 2012, 156: ITC3.Gupta K, Trautner B. In the clinic. Urinary tract infection. Ann Intern Med, 2012, 156: ITC3.Walker E, Lyman A, Gupta K et al. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Clin Infect Dis, 2016, 63: 960.Walker E, Lyman A, Gupta K et al. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Clin Infect Dis, 2016, 63: 960.Linsenmeyer K, Strymish J, Gupta K. Two Simple Rules for Improving the Accuracy of Empiric Treatment of Multidrug-Resistant Urinary Tract Infections. Antimicrob Agents Chemother, 2015, 59: 7593.Linsenmeyer K, Strymish J, Gupta K. Two Simple Rules for Improving the Accuracy of Empiric Treatment of Multidrug-Resistant Urinary Tract Infections. Antimicrob Agents Chemother, 2015, 59: 7593.Naber KG, Schito G, Botto H et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol, 2008, 54: 1164.Naber KG, Schito G, Botto H et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol, 2008, 54: 1164.Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis, 2011, 52: e103.Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis, 2011, 52: e103.Swami SK, Liesinger JT, Shah N et al. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc, 2012, 87: 753.Swami SK, Liesinger JT, Shah N et al. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc, 2012, 87: 753.Talan DA, Krishnadasan A, Abrahamian FM et al. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinoloneresistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis, 2008, 47: 1150.Talan DA, Krishnadasan A, Abrahamian FM et al. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinoloneresistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis, 2008, 47: 1150.Gupta K, Hooton TM, Miller L. Uncomplicated UTI IDSA Guideline Committee. Managing uncomplicated urinary tract infection–making sense out of resistance data. Clin Infect Dis, 2011, 53: 1041.Gupta K, Hooton TM, Miller L. Uncomplicated UTI IDSA Guideline Committee. Managing uncomplicated urinary tract infection–making sense out of resistance data. Clin Infect Dis, 2011, 53: 1041.Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother, 2009, 53: 1285.Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother, 2009, 53: 1285.Ho PL, Yip KS, Chow KH et al. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn Microbiol Infect Dis, 2010, 66: 87.Ho PL, Yip KS, Chow KH et al. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn Microbiol Infect Dis, 2010, 66: 87.Lautenbach E. Editorial commentary: flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clin Infect Dis, 2013, 57: 1266.Lautenbach E. Editorial commentary: flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clin Infect Dis, 2013, 57: 1266.Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA, 2014, 311: 844.Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA, 2014, 311: 844.Juthani-Mehta M, Quagliarello V, Perrelli E et al. Clinical features to identify urinary tract infection in nursing home residents: a cohort study. J Am Geriatr Soc, 2009, 57: 963.Juthani-Mehta M, Quagliarello V, Perrelli E et al. Clinical features to identify urinary tract infection in nursing home residents: a cohort study. J Am Geriatr Soc, 2009, 57: 963.Sundvall PD, Ulleryd P, Gunnarsson RK. Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC Fam Pract, 2011, 12: 36.Sundvall PD, Ulleryd P, Gunnarsson RK. Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC Fam Pract, 2011, 12: 36.Sundvall PD, Elm M, Ulleryd P et al. Interleukin-6 concentrations in the urine and dipstick analyses were related to bacteriuria but not symptoms in the elderly: a cross sectional study of 421 nursing home residents. BMC Geriatr, 2014, 14: 88.Sundvall PD, Elm M, Ulleryd P et al. Interleukin-6 concentrations in the urine and dipstick analyses were related to bacteriuria but not symptoms in the elderly: a cross sectional study of 421 nursing home residents. BMC Geriatr, 2014, 14: 88.Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: A prospective cohort study. Arch Gerontol Geriatr, 2017, 72: 127.Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: A prospective cohort study. Arch Gerontol Geriatr, 2017, 72: 127.Nace DA, Drinka PJ, Crnich CJ. Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. J Am Med Dir Assoc, 2014, 15: 133.Nace DA, Drinka PJ, Crnich CJ. Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. J Am Med Dir Assoc, 2014, 15: 133.Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med, 2013, 369: 1883.Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med, 2013, 369: 1883.Coyne KS, Sexton CC, Vats V et al. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology, 2011, 77: 1081.Coyne KS, Sexton CC, Vats V et al. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology, 2011, 77: 1081.Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med, 2007, 167: 2207.Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med, 2007, 167: 2207.McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc, 2011, 86: 480.McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc, 2011, 86: 480.Huttner A, Verhaegh EM, Harbarth S et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother, 2015, 70: 2456.Huttner A, Verhaegh EM, Harbarth S et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother, 2015, 70: 2456.Singh N, Gandhi S, McArthur E, et al. Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women. CMAJ, 2015, 187: 648.Singh N, Gandhi S, McArthur E, et al. Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women. CMAJ, 2015, 187: 648.By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 2015, 63: 2227.By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 2015, 63: 2227.Santos JM, Batech M, Pelter MA, Deamer RL. Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study. J Am Geriatr Soc, 2016, 64: 798.Santos JM, Batech M, Pelter MA, Deamer RL. Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study. J Am Geriatr Soc, 2016, 64: 798.Falagas ME, Vouloumanou EK, Togias AG et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother, 2010, 65: 1862.Falagas ME, Vouloumanou EK, Togias AG et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother, 2010, 65: 1862.Huttner A, Kowalczyk A, Turjeman A et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: A randomized clinical trial. JAMA, 2018, doi: 10.1001/jama.2018.3627.Huttner A, Kowalczyk A, Turjeman A et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: A randomized clinical trial. JAMA, 2018, doi: 10.1001/jama.2018.3627.Datta R, Juthani-Mehta M. Nitrofurantoin vs Fosfomycin: Rendering a Verdict in a Trial of Acute Uncomplicated Cystitis. JAMA, 2018, 319: 1771.Datta R, Juthani-Mehta M. Nitrofurantoin vs Fosfomycin: Rendering a Verdict in a Trial of Acute Uncomplicated Cystitis. JAMA, 2018, 319: 1771.Rodríguez-Baño J, Alcalá JC, Cisneros JM et al. Community infections caused by extendedspectrum beta-lactamase-producing Escherichia coli. Arch Intern Med, 2008, 168: 1897.Rodríguez-Baño J, Alcalá JC, Cisneros JM et al. Community infections caused by extendedspectrum beta-lactamase-producing Escherichia coli. Arch Intern Med, 2008, 168: 1897.Zalmanovici Trestioreanu A, Green H, Paul M et al. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database Syst Rev, 2010: CD007182.Zalmanovici Trestioreanu A, Green H, Paul M et al. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database Syst Rev, 2010: CD007182.FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections, warns about disabling side effects that can occur together. http: //www.fda.gov/Drugs/DrugSafety/ucm500143.htm (Accessed on May 26, 2016).FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections, warns about disabling side effects that can occur together. http: //www.fda.gov/Drugs/DrugSafety/ucm500143.htm (Accessed on May 26, 2016).Little P, Moore MV, Turner S et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ, 2010, 340: 199.Little P, Moore MV, Turner S et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ, 2010, 340: 199.Qiao LD, Chen S, Yang Y et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open, 2013, 3: e004152.Qiao LD, Chen S, Yang Y et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open, 2013, 3: e004152.Jansåker F, Frimodt-Møller N, Sjögren I, Dahl Knudsen J. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother, 2014, 69: 769Jansåker F, Frimodt-Møller N, Sjögren I, Dahl Knudsen J. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother, 2014, 69: 769Gágyor I, Bleidorn J, Kochen MM et al. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ, 2015, 351: h6544.Gágyor I, Bleidorn J, Kochen MM et al. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ, 2015, 351: h6544.Kronenberg A, Bütikofer L, Odutayo A et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ, 2017, 359: j4784.Kronenberg A, Bütikofer L, Odutayo A et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ, 2017, 359: j4784.Klimberg I, Shockey G, Ellison H et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin, 2005, 21: 1241.Klimberg I, Shockey G, Ellison H et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin, 2005, 21: 1241.

The authors declare that there are no conflicts of interest present.